What is the recommended workup and management for a patient presenting with retinitis?

Workup and Management of Retinitis

The approach to retinitis depends critically on distinguishing between infectious retinitis (primarily CMV in immunocompromised patients) and acute retinal arterial ischemia, as these require fundamentally different urgent evaluations and treatments to prevent blindness and systemic complications.

Initial Clinical Assessment

Determine Patient's Immune Status and Risk Factors

• Check HIV status and CD4+ count immediately - CMV retinitis occurs almost exclusively when CD4+ counts are <50 cells/µL 1
• Assess for other immunocompromising conditions (transplant recipients, immunosuppressive therapy) 2
• Evaluate cardiovascular risk factors and embolic sources if vascular etiology suspected 1

Fundoscopic Examination Findings Guide Diagnosis

• CMV retinitis: Fluffy yellow-white retinal lesions with or without intraretinal hemorrhage ("pizza pie" appearance), minimal vitreous inflammation, characteristic brushfire pattern with granular white leading edge 1, 3
• Acute retinal arterial ischemia: Retinal whitening, cherry-red spot, embolic plaques visible in vessels 1
• Syphilitic retinitis: Necrotizing retinitis that may mimic CMV, requires serological confirmation 4

Diagnostic Workup

For Suspected CMV Retinitis (Immunocompromised Patients)

• Clinical diagnosis is primarily based on characteristic fundus appearance in susceptible patients 2
• PCR of intraocular fluid for CMV DNA when confirmation is necessary or diagnosis uncertain 2
• CD4+ count and HIV viral load if not already known 1
• Do NOT treat CMV viremia without end-organ disease - pre-emptive therapy for asymptomatic viremia is not recommended 1

For Suspected Acute Retinal Arterial Ischemia

• Urgent brain MRI with diffusion-weighted imaging (DWI) within 7 days - up to 31% of patients have silent cerebral infarctions, with 27-76% of CRAO patients and 11.8-30.8% of transient monocular visual loss patients showing acute cerebral infarctions 1
• Complete stroke workup including carotid imaging, echocardiography, and cardiovascular risk assessment 1
• This population has extremely high risk of acute coronary events and stroke, requiring urgent systemic evaluation 1

For Atypical or Unclear Cases

• Syphilis serology (RPR/VDRL and treponemal testing) - ocular syphilis can present as necrotizing retinitis mimicking viral causes 4
• Consider additional serologies based on exposure history: Lyme disease, toxoplasmosis, tuberculosis, histoplasmosis 5
• Herpes simplex and varicella-zoster testing if acute retinal necrosis suspected 6

Management

CMV Retinitis Treatment

Sight-Threatening Lesions (Adjacent to Optic Nerve or Fovea)

• Ganciclovir intraocular implant PLUS oral valganciclovir - this combination is superior to IV or oral ganciclovir alone for preventing relapse 1
• Consider immediate intravitreous ganciclovir injection at diagnosis to deliver high local concentration until implant placement 1

Small Peripheral Lesions

• Oral valganciclovir alone may be adequate 1
• Even in ART-naïve patients with small peripheral lesions, systemic anti-CMV therapy for initial 3-6 months is beneficial to prevent complications (immune recovery retinitis, retinal detachment) and reduce mortality 1

Alternative Agents

• IV ganciclovir, IV foscarnet, or IV cidofovir are effective alternatives 1
• Systemic therapy reduces morbidity in the contralateral eye and should be considered when choosing between oral, IV, and local options 1

Antiretroviral Therapy

• Initiate or optimize ART - immune reconstitution is the definitive long-term strategy 1
• ART takes 3-6 months to achieve sufficient immune recovery to control retinitis 1
• Maintenance therapy can be discontinued after 6 months if retinitis remains inactive with immune reconstitution (CD4+ >100 cells/µL) 2

Acute Retinal Arterial Ischemia Management

• Treat as retinal stroke equivalent - urgent evaluation analogous to cerebral ischemia management 1
• Identify and treat embolic sources immediately to prevent recurrent TIAs or stroke 1
• Patients with ipsilateral carotid stenosis and multiple small cerebral infarctions have very high stroke risk requiring immediate intervention 1

Syphilitic Retinitis

• CDC-approved neurosyphilis regimen with IV antibiotics (typically IV penicillin G) for all ocular manifestations 4
• Rapid visual recovery expected with appropriate antibiotic treatment 4

Monitoring and Follow-Up

CMV Retinitis Patients

• Regular ophthalmologic follow-up is mandatory even after immune recovery, as relapse can occur at CD4+ counts as high as 1,250 cells/µL 1
• Relapse rate is 0.03/person-year even with CD4+ >100 cells/µL 1
• Distinguish immune recovery uveitis from CMVR relapse - IRU occurs with immune reconstitution and requires different management 2

High-Risk Screening

• Patients with CD4+ <50 cells/µL should have regular funduscopic examinations by ophthalmologist 1
• Educate patients about floaters and visual changes; advise regular self-assessment of visual acuity (e.g., reading newsprint) 1

Critical Pitfalls to Avoid

• Do not delay brain MRI in acute retinal arterial ischemia - silent cerebral infarctions are common and indicate very high stroke risk 1
• Do not withhold anti-CMV therapy in small peripheral lesions - complications are more common with larger lesions, and mortality reduction is documented with systemic therapy 1
• Do not miss syphilis - always obtain serologies in necrotizing retinitis, especially if no response to antiviral therapy 4
• Do not treat asymptomatic CMV viremia without end-organ disease - no clinical benefit demonstrated 1